Saxagliptin monohydrate

Saxagliptin monohydrate is an orally active hypoglycemic drug used mainly to manage type 2 diabetes mellitus. It belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. Saxagliptin helps control blood sugar levels by increasing levels of incretin hormones in the body, which then stimulate the pancreas to release more insulin when glucose levels are high and reduce the amount of glucose produced by the liver. This glucose-dependent mechanism lowers both fasting and postprandial blood sugar levels. It is grouped under the following drug class(es): DPP-4 inhibitors and Hypoglycemics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Saxagliptin hydrate and Saxagliptin anhydrous. Its PubChem CID is 53297473.

CAS No 945667-22-1
Molecular Formula C18H27N3O3
Molecular Weight 333.4 g/mol
Synonyms (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;hydrate

Frequently Asked Questions